Carregando…
84 empresas que cobrimos, 78 delas avaliadas
Todas as empresas daqui passadas pelas mesmas cinco verificações sobre crescimento e geração de caixa. Descreve o segmento como ele se divulga hoje — não qual destas comprar.
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LIMITED | A | US$ 45,7B | US$ 39,19 | 65,32 | US$ 17,3B | 4,1% |
| HLN | Haleon plc | B+ | US$ 41,4B | US$ 9,26 | 18,87 | US$ 14,6B | 15,1% |
| TAK | Takeda Pharmaceutical Company Limited | B | US$ 30,3B | US$ 18,86 | 44,01 | US$ 28,7B | -3,4% |
| ZTS | Zoetis Inc. | A+ | US$ 29,4B | US$ 71,05 | 11,71 | US$ 9,5B | 27,5% |
| VTRS | VIATRIS INC. | C | US$ 20,5B | US$ 17,83 | — | US$ 14,7B | -23,9% |
| UTHR | United Therapeutics Corporation | B+ | US$ 20,4B | US$ 475,45 | 17,02 | US$ 3,2B | 41,6% |
| NBIX | NEUROCRINE BIOSCIENCES INC | A+ | US$ 14,1B | US$ 138,40 | 20,29 | US$ 3,4B | 20,9% |
| ELAN | Elanco Animal Health Incorporated | A | US$ 11,1B | US$ 22,31 | — | US$ 5B | -4,0% |
| RDY | DR. REDDY’S LABORATORIES LIMITED | B+ | US$ 10,2B | US$ 12,25 | 17,35 | US$ 3,5B | 12,8% |
| ALKS | Alkermes plc. | B | US$ 6,9B | US$ 40,85 | 107,50 | US$ 1,7B | 4,0% |
| HIMS | HIMS & HERS HEALTH, INC. | A- | US$ 6,8B | US$ 29,42 | — | US$ 2,6B | -5,5% |
| LNTH | Lantheus Holdings, Inc. | A+ | US$ 6,5B | US$ 99,74 | 24,15 | US$ 1,6B | 17,7% |
| AMRX | AMNEAL PHARMACEUTICALS, INC. | C | US$ 6,3B | US$ 19,77 | 40,35 | US$ 3,1B | 5,0% |
| KNSA | Kiniksa Pharmaceuticals International, plc | A | US$ 6,2B | US$ 75,08 | 82,51 | US$ 754M | 9,7% |
| LQDA | LIQUIDIA CORPORATION | A+ | US$ 6,1B | US$ 68,43 | 49,23 | US$ 450,9M | 30,7% |
| INDV | Indivior Pharmaceuticals, Inc. | D | US$ 4,2B | US$ 35,82 | 12,84 | US$ 1,3B | 26,7% |
| AMLX | Amylyx Pharmaceuticals, Inc. | D | US$ 3,3B | US$ 29,49 | — | US$ 0,00 | — |
| RGC | Regencell Bioscience Holdings Limited | sem nota | US$ 3,1B | US$ 6,17 | — | — | — |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | C- | US$ 2,5B | US$ 42,66 | — | US$ 830,4M | -13,2% |
| HCM | HutchMED (China) LIMITED | D | US$ 2,4B | US$ 13,94 | 26,81 | US$ 549,1M | 3,3% |
| TRLV | TRULIEVE CANNABIS CORP. | D | US$ 2,4B | US$ 12,21 | — | US$ 1,1B | -41,8% |
| PBH | PRESTIGE CONSUMER HEALTHCARE INC. | C+ | US$ 2,2B | US$ 46,61 | 13,06 | US$ 1,1B | 15,6% |
| BCRX | BIOCRYST PHARMACEUTICALS, INC. | A | US$ 2,2B | US$ 8,59 | — | US$ 940,6M | -40,9% |
| PRGO | Perrigo Company plc | F- | US$ 2,1B | US$ 15,42 | — | US$ 4,1B | -41,9% |
| BHC | Bausch Health Companies Inc. | A | US$ 2,1B | US$ 5,69 | — | US$ 10,9B | -10,1% |
| ALVO | ALVOTECH | B | US$ 1,8B | US$ 5,75 | 57,50 | US$ 586,3M | 4,8% |
| XERS | XERIS BIOPHARMA HOLDINGS, INC. | F- | US$ 1,7B | US$ 9,10 | — | US$ 335,4M | -5,1% |
| ETON | Eton Pharmaceuticals, Inc. | A+ | US$ 1,6B | US$ 57,68 | — | US$ 105,6M | 12,0% |
| ANIP | ANI PHARMACEUTICALS, INC | A+ | US$ 1,6B | US$ 74,00 | 15,98 | US$ 978,4M | 11,1% |
| PAHC | Phibro Animal Health Corporation | B | US$ 1,4B | US$ 34,45 | 14,12 | US$ 1,5B | 6,6% |
| HROW | Harrow, Inc. | B- | US$ 1,2B | US$ 33,07 | — | US$ 275,6M | -13,5% |
| CRON | CRONOS GROUP INC. | A | US$ 1,2B | US$ 3,34 | 16,70 | US$ 179,1M | 39,1% |
| AMPH | Amphastar Pharmaceuticals, Inc. | A+ | US$ 1,1B | US$ 26,13 | 15,46 | US$ 730M | 10,8% |
| PCRX | PACIRA BIOSCIENCES, INC. | A | US$ 1B | US$ 25,12 | 71,77 | US$ 746,2M | 2,0% |
| COLL | Collegium Pharmaceutical, Inc. | A+ | US$ 733,5M | US$ 22,53 | 18,17 | US$ 808,2M | 5,9% |
| IRWD | IRONWOOD PHARMACEUTICALS, INC. | C+ | US$ 682,4M | US$ 4,13 | 5,36 | US$ 389,3M | 33,4% |
| AQST | Aquestive Therapeutics, Inc. | C | US$ 587,4M | US$ 4,68 | — | US$ 54,1M | -144,6% |
| TLRY | Tilray Brands, Inc. | C- | US$ 562,5M | US$ 4,13 | — | US$ 915,5M | -13,3% |
| GLAS | Glass House Brands Inc. | D- | US$ 557,2M | US$ 6,80 | — | US$ 152,9M | -33,7% |
| EOLS | EVOLUS, INC. | B | US$ 526,4M | US$ 7,97 | — | US$ 316,5M | -10,8% |
| KMDA | KAMADA LTD | C | US$ 503M | US$ 8,72 | 22,95 | US$ 191,8M | 11,6% |
| TKNO | ALPHA TEKNOVA, INC. | B- | US$ 500,9M | US$ 9,33 | — | US$ 43,7M | -38,4% |
| CGC | Canopy Growth Corp | D- | US$ 398,3M | US$ 0,94 | — | US$ 207,3M | -79,2% |
| EBS | EMERGENT BIOSOLUTIONS INC. | C | US$ 348,1M | US$ 6,79 | — | US$ 770,2M | -23,0% |
| BIOA | BIOAGE LABS, INC. | D- | US$ 323,6M | US$ 7,05 | — | US$ 10,4M | -912,3% |
| INCR | INTERCURE LTD. | C- | US$ 284,9M | US$ 5,21 | — | US$ 88,2M | -13,2% |
| EVO | Evotec SE | D- | US$ 277,3M | US$ 1,56 | — | US$ 897M | -13,1% |
| ANIK | Anika Therapeutics, Inc. | B- | US$ 272,6M | US$ 20,37 | — | US$ 120,7M | -3,1% |
| AKBA | AKEBIA THERAPEUTICS, INC. | C | US$ 248,3M | US$ 0,90 | — | US$ 219,1M | -13,5% |
| SIGA | Siga Technologies INC | F- | US$ 247,9M | US$ 3,45 | — | US$ 53,7M | -5,2% |
| ACB | AURORA CANNABIS INC | D | US$ 230,6M | US$ 4,10 | 145,20 | US$ 226,3M | -42,4% |
| ORGO | ORGANOGENESIS HOLDINGS INC. | B- | US$ 181,4M | US$ 1,41 | — | US$ 457,5M | -18,4% |
| CRDL | Cardiol Therapeutics Inc. | sem nota | US$ 171,4M | US$ 1,71 | — | — | — |
| DERM | Journey Medical Corp | C- | US$ 168,2M | US$ 6,14 | — | US$ 68,2M | -9,0% |
| ADCT | ADC Therapeutics SA | D | US$ 162,1M | US$ 1,27 | — | US$ 79,6M | -121,8% |
| LFCR | LIFECORE BIOMEDICAL, INC. | D | US$ 159M | US$ 4,20 | — | US$ 128,9M | -30,0% |
| CPIX | Cumberland Pharmaceuticals Inc. | F- | US$ 114M | US$ 7,61 | — | US$ 39,9M | -27,4% |
| OGI | ORGANIGRAM HOLDINGS INC. | C- | US$ 104,8M | US$ 1,10 | — | US$ 183M | -9,6% |
| CTOR | Citius Oncology, Inc. | sem nota | US$ 97,6M | US$ 1,05 | — | — | — |
| ZYBT | Zhengye Biotechnology Holding Limited | D | US$ 61,8M | US$ 1,31 | 35,03 | US$ 17,3M | -60,0% |
| SCYX | SCYNEXIS, Inc. | F- | US$ 43,7M | US$ 4,39 | 15,14 | US$ 19,2M | -53,3% |
| IMCC | IM Cannabis Corp. | C | US$ 36,4M | US$ 2,84 | — | US$ 32,3M | -39,1% |
| RMTI | ROCKWELL MEDICAL, INC. | B- | US$ 33,7M | US$ 8,37 | — | US$ 69,4M | -7,3% |
| CPHI | CHINA PHARMA HOLDINGS, INC. | C- | US$ 32,3M | US$ 0,75 | — | US$ 3,9M | -114,3% |
| BGM | BGM Group Ltd | F- | US$ 27,2M | US$ 0,24 | — | US$ 37,9M | -52,6% |
| AYTU | AYTU BIOPHARMA, INC | C | US$ 24,8M | US$ 2,28 | — | US$ 57,6M | -24,8% |
| TXMD | TherapeuticsMD, Inc. | F- | US$ 23,7M | US$ 2,05 | — | US$ 3,3M | -6,6% |
| RDHL | REDHILL BIOPHARMA LTD. | F- | US$ 22,5M | US$ 0,50 | — | US$ 286K | -150,0% |
| BFRI | Biofrontera Inc. | B- | US$ 17,5M | US$ 1,18 | — | US$ 46,2M | -13,8% |
| TLPH | TALPHERA, INC. | C- | US$ 16,8M | US$ 1,18 | — | US$ 1K | -1.507.600,0% |
| CABR | CARING BRANDS, INC. | F- | US$ 12,8M | US$ 1,24 | — | US$ 4,2K | -183.255,2% |
| APUS | APIMEDS PHARMACEUTICALS US, INC. | sem nota | US$ 10,9M | US$ 7,25 | — | — | — |
| INM | INMED PHARMACEUTICALS INC. | D- | US$ 7,6M | US$ 1,38 | — | US$ 4,5M | -278,7% |
| SNOA | SONOMA PHARMACEUTICALS, INC. | B- | US$ 6,1M | US$ 1,27 | — | US$ 21,9M | -10,3% |
| GELS | Gelteq Limited | D- | US$ 5,2M | US$ 0,55 | — | US$ 116,3K | -4.011,9% |
| SBFM | Sunshine Biopharma Inc. | C- | US$ 3,3M | US$ 0,84 | — | US$ 35,3M | -16,5% |
| SHPH | SHUTTLE PHARMACEUTICALS HOLDINGS, INC. | sem nota | US$ 3M | US$ 4,01 | — | — | — |
| UPC | Universe Pharmaceuticals INC | D- | US$ 2,7M | US$ 4,75 | — | US$ 17,9B | -20,6% |
| SXTC | China SXT Pharmaceuticals, Inc. | F- | US$ 2,5M | US$ 2,57 | — | US$ 1,1M | -545,2% |
| YCBD | cbdMD, Inc. | D- | US$ 1,9M | US$ 0,47 | — | US$ 20,9M | -13,8% |
| IXHL | Incannex Healthcare Inc. | F- | US$ 1,7M | US$ 3,32 | — | US$ 0,00 | — |
| PRFX | PRF Technologies Ltd. | B- | US$ 811,3K | US$ 0,98 | — | US$ 17K | -29.541,2% |
| AKAN | AKANDA CORP. | F | US$ 210,3K | US$ 3,05 | 0,24 | US$ 258,1K | -17.690,2% |
| OPTH | Optimi Health Corp. | sem nota | — | US$ 4,82 | — | — | — |
Fundamentos de documentos entregues à SEC, preços da última coleta de dados de mercado. Ordene por qualquer coluna; empresas sem número vão para o fim nos dois sentidos.
Ordenado por valor de mercado, do maior para o menor; clique em qualquer coluna para reordenar. Empresas sem número vão para o fim nos dois sentidos, porque um P/L faltando significa prejuízo e não que esteja barata. Nada aqui é recomendação.